InMed Pharmaceuticals Inc.
INM
$2.96
$0.24378.97%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -63.88% | -17.03% | -26.15% | -20.77% | -16.67% |
Total Receivables | -29.58% | 71.61% | 35.48% | 21.96% | 356.99% |
Inventory | 48.15% | 7.68% | -23.02% | -10.22% | -53.84% |
Prepaid Expenses | -42.14% | -30.74% | -4.08% | 46.53% | 34.60% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -53.68% | -12.24% | -23.32% | -15.02% | -15.75% |
|
|||||
Total Current Assets | -53.68% | -12.24% | -23.32% | -15.02% | -15.75% |
Net Property, Plant & Equipment | -16.89% | 118.34% | 72.80% | 82.02% | 110.41% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -8.75% | -8.56% | -8.38% | -8.21% | -8.02% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | -1.77% | -4.67% | -32.20% | -41.55% |
Total Assets | -44.27% | -4.14% | -16.19% | -9.31% | -9.84% |
|
|||||
Total Accounts Payable | 87.47% | 18.19% | 15.07% | -45.41% | -60.24% |
Total Accrued Expenses | -10.80% | -15.88% | -7.31% | -33.54% | -26.69% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 15.24% | 44.81% | -15.41% | -18.44% | -12.09% |
Total Finance Division Other Current Liabilities | -90.57% | -- | 153.09% | 237.04% | 704.94% |
Total Other Current Liabilities | -90.57% | -- | 153.09% | 237.04% | 704.94% |
Total Current Liabilities | 6.57% | 7.22% | -1.44% | -32.64% | -30.00% |
|
|||||
Total Current Liabilities | 6.57% | 7.22% | -1.44% | -32.64% | -30.00% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -34.08% | -- | 3,930.63% | 896.15% | 336.54% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -6.57% | 54.55% | 29.76% | -3.77% | -3.92% |
|
|||||
Common Stock & APIC | 1.12% | 4.97% | 4.23% | 4.23% | 4.23% |
Retained Earnings | -7.51% | -6.56% | -7.57% | -6.01% | -6.41% |
Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Common Equity | -51.60% | -12.35% | -23.85% | -10.36% | -10.90% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -51.60% | -12.35% | -23.85% | -10.36% | -10.90% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -51.60% | -12.35% | -23.85% | -10.36% | -10.90% |
|